Breaking News Instant updates and real-time market news.

FCFS

First Cash Financial

$90.91

2.18 (2.46%)

06:12
04/24/19
04/24
06:12
04/24/19
06:12

First Cash Financial CEO says 'we are off to a great start in 2019'

"With these outstanding first quarter results, we are off to a great start in 2019. We have raised our full year earnings guidance despite additional short-term earnings drags from the front loading of our de novo store openings and additional administrative expenses in Latin America due to the significant acquisition activity over the past twelve months. We believe that we will begin to see even greater profitability growth in the latter part of the year as the de novo stores ramp revenues and we realize cost synergy opportunities in Latin America. In summary, we remain extremely optimistic about continued revenue growth, store expansion in multiple markets and further opportunities to improve margins. Coupled with our strong cash flows and commitment to shareholder returns, we believe that we are driving significant shareholder value," concluded Rick Wessel, CEO.

  • 06

    May

  • 13

    Nov

FCFS First Cash Financial
$90.91

2.18 (2.46%)

10/26/18
WEDB
10/26/18
UPGRADE
WEDB
Outperform
First Cash Financial upgraded to Outperform from Neutral at Wedbush
12/03/18
WEDB
12/03/18
DOWNGRADE
WEDB
Neutral
First Cash Financial downgraded to Neutral from Outperform at Wedbush
01/08/19
JEFF
01/08/19
DOWNGRADE
Target $5
JEFF
Hold
Jefferies downgrades Elevate Credit on lack of earnings visibility
Jefferies analyst John Hecht downgraded Elevate Credit (ELVT) to Hold from Buy and lowered his price target for the shares to $5 from $9.50. The analyst cites the company's credit issues and resulting lack of earnings visibility for the downgrade. He's becoming more selective on the Consumer Finance space and names his top picks as Aaron's (AAN), Enova International (ENVA), First Cash Financial (FCFS) and OneMain Holdings (OMF). Growth prospects remain solid for some and credit performance has been consistent for most, while the market appears to be pricing in an economic downturn, Hecht tells investors in a research note.
01/31/19
WEDB
01/31/19
NO CHANGE
Target $90
WEDB
Neutral
Wedbush sees First Cash Financial reporting EPS at upper end of guidance
Wedbush analyst Henry Coffey said that while First Cash Financial's guidance was disappointing, the outlook reflects a loss of 25c-30c per share associated with the closure of Ohio stores and the exit of consumer lending in other U.S. markets and the value he places on the contribution from consumer lending "is very low." While he had been expecting a slower exit from the Ohio pay day loan and installment loan products and less of a final hit to EPS, he also thinks moving away from this product makes sense for a number of reasons. Coffey, who believes First Cash will report EPS at the upper end of its guidance, keeps a Neutral rating and $90 price target on the stock.

TODAY'S FREE FLY STORIES

KMI

Kinder Morgan

07:55
06/26/19
06/26
07:55
06/26/19
07:55
Downgrade
Kinder Morgan rating change  »

Kinder Morgan downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEP

Holly Energy Partners

07:55
06/26/19
06/26
07:55
06/26/19
07:55
Downgrade
Holly Energy Partners rating change  »

Holly Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

GEL

Genesis Energy

$21.59

-0.38 (-1.73%)

07:55
06/26/19
06/26
07:55
06/26/19
07:55
Downgrade
Genesis Energy rating change  »

Genesis Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMB

Williams

$26.80

-0.36 (-1.33%)

07:55
06/26/19
06/26
07:55
06/26/19
07:55
Upgrade
Williams rating change  »

Williams upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLRN

Acceleron

$39.60

-0.49 (-1.22%)

07:52
06/26/19
06/26
07:52
06/26/19
07:52
Hot Stocks
Acceleron completes target enrollment in PULSAR Phase 2 trial of sotatercept »

Acceleron Pharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 04

    Apr

KSHB

KushCo Holdings

$0.00

(0.00%)

07:52
06/26/19
06/26
07:52
06/26/19
07:52
Initiation
KushCo Holdings initiated  »

Benchmark starts KushCo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

AYX

Alteryx

$104.20

-2 (-1.88%)

07:52
06/26/19
06/26
07:52
06/26/19
07:52
Recommendations
Alteryx analyst commentary  »

Alteryx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSN

Parsons

$36.77

-0.045 (-0.12%)

07:51
06/26/19
06/26
07:51
06/26/19
07:51
Downgrade
Parsons rating change  »

Parsons downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENR

Energizer

$37.51

-0.625 (-1.64%)

07:48
06/26/19
06/26
07:48
06/26/19
07:48
Upgrade
Energizer rating change  »

Energizer upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$156.00

-4.88 (-3.03%)

, WMT

Walmart

$110.72

-0.53 (-0.48%)

07:48
06/26/19
06/26
07:48
06/26/19
07:48
Recommendations
FedEx, Walmart, Target, Amazon.com analyst commentary  »

FedEx price target…

FDX

FedEx

$156.00

-4.88 (-3.03%)

WMT

Walmart

$110.72

-0.53 (-0.48%)

TGT

Target

$85.70

-1.03 (-1.19%)

AMZN

Amazon.com

$1,879.26

-34.17 (-1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 30

    Jul

  • 31

    Jul

  • 15

    Aug

  • 21

    Aug

  • 17

    Sep

  • 13

    Nov

07:45
06/26/19
06/26
07:45
06/26/19
07:45
General news
U.S. MBA reported mortgage applications bounced 1.3% »

U.S. MBA reported…

UPWK

Upwork

$15.07

-0.41 (-2.65%)

, FVRR

Fiverr

$29.00

-0.2 (-0.68%)

07:44
06/26/19
06/26
07:44
06/26/19
07:44
Upgrade
Upwork, Fiverr rating change  »

Upwork upgraded to Buy…

UPWK

Upwork

$15.07

-0.41 (-2.65%)

FVRR

Fiverr

$29.00

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LINX

Linx S.A.

$0.00

(0.00%)

07:41
06/26/19
06/26
07:41
06/26/19
07:41
Syndicate
Linx S.A. 32.8M share IPO priced at $9.40 »

We are told the official…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

07:40
06/26/19
06/26
07:40
06/26/19
07:40
General news
Treasury Market Outlook: Treasury yields jumped higher »

Treasury Market Outlook:…

BBRX

Braeburn Pharmaceuticals

$0.00

(0.00%)

07:38
06/26/19
06/26
07:38
06/26/19
07:38
Initiation
Braeburn Pharmaceuticals initiated  »

Braeburn Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FISV

Fiserv

$90.27

-0.53 (-0.58%)

07:38
06/26/19
06/26
07:38
06/26/19
07:38
Upgrade
Fiserv rating change at Northcoast »

Fiserv upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVSI

Envision Solar

$5.11

-0.22 (-4.13%)

07:38
06/26/19
06/26
07:38
06/26/19
07:38
Initiation
Envision Solar initiated at Maxim »

Envision Solar initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$1.66

-0.05 (-2.93%)

07:37
06/26/19
06/26
07:37
06/26/19
07:37
Initiation
Kadmon initiated  »

Oppenheimer bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCR

Novocure

$57.44

-0.58 (-1.00%)

07:37
06/26/19
06/26
07:37
06/26/19
07:37
Hot Stocks
Novocure announces publication of IQWiG rapid report for Optune »

Novocure announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSTR

CapStar Financial

$15.01

0.05 (0.33%)

07:37
06/26/19
06/26
07:37
06/26/19
07:37
Downgrade
CapStar Financial rating change at Sandler ONeill »

CapStar Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCRX

Pacira

$43.53

0.39 (0.90%)

07:35
06/26/19
06/26
07:35
06/26/19
07:35
Hot Stocks
Pacira says results show EXPAREL associated with 'significantly less' opioid use »

Pacira BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ODT

Odonate Therapeutics

$28.14

-0.29 (-1.02%)

07:35
06/26/19
06/26
07:35
06/26/19
07:35
Syndicate
Odonate Therapeutics 4.75M share Spot Secondary priced at $26.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 26

    Jun

X

U.S. Steel

$14.93

0.48 (3.32%)

07:35
06/26/19
06/26
07:35
06/26/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGO

Eldorado Gold

$5.46

-0.02 (-0.36%)

07:34
06/26/19
06/26
07:34
06/26/19
07:34
Upgrade
Eldorado Gold rating change  »

Eldorado Gold upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XON

Intrexon

$7.34

0.17 (2.37%)

07:33
06/26/19
06/26
07:33
06/26/19
07:33
Hot Stocks
Intrexon doses first patient in Phase 1/1b study of Acute Myeloid Leukemia drug »

Intrexon's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.